Condensed Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Common Stock Subordinate Voting	Common Stock Multiple Voting	Additional Paid-In Capital	Accumulated OCI	Accumulated Deficit
Balance at Dec. 31, 2020	$ 75,868			$ 120,220	$ 284	$ (44,636)
Balance, Shares at Dec. 31, 2020		306,135,160	550,000
Issuance of Subordinate Voting Shares and Warrants, net of share issuance costs	82,113			82,113
Issuance of Subordinate Voting Shares and Warrants, net of share issuance costs, Shares		26,930,000
Subordinate Voting Shares conversion to Multiple Voting Shares		(3,500,000)	35,000
Issuance of Subordinate Voting Shares for vested director compensation	66			66
Issuance of Subordinate Voting Shares for vested director compensation, Shares		622,435
HealthMode acquisition	27,159			27,159
HealthMode acquisition, Shares			81,497
Exercise of warrants	6,697			6,697
Exercise of warrants, Shares		4,228,880
Exercise of stock options	1,178			1,178
Exercise of stock options, Shares		4,519,879
Stock-based compensation expense	1,213			1,213
Net loss and Comprehensive loss	(13,700)				59	(13,759)
Balance at Mar. 31, 2021	180,594			238,646	343	(58,395)
Balance, Shares at Mar. 31, 2021		338,936,354	666,497
Balance at Dec. 31, 2021	151,664			288,290	1,046	(137,672)
Balance, Shares at Dec. 31, 2021		421,444,157	4,521
Multiple Voting Shares conversion to Subordinate Voting Shares		452,060	(4,521)
Exercise of warrants	118			118
Exercise of warrants, Shares		187,851
Exercise of stock options	$ 123			123
Exercise of stock options, Shares	317,708	317,708
Withholding taxes paid on vested restricted share units	$ (407)			(407)
Stock-based compensation expense	3,807			3,807
Net loss and Comprehensive loss	(18,500)				(49)	(18,451)
Balance at Mar. 31, 2022	$ 136,805			$ 291,931	$ 997	$ (156,123)
Balance, Shares at Mar. 31, 2022		422,401,776